• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Sialoadenosis produced by drug-treatment of hypertonicity. I. Experimental studies on the effects of guanethidine (Ismelin) on the parotid glands of the rat (author's transl)].

作者信息

Chilla R, Rieger R, Arglebe C

出版信息

Arch Otorhinolaryngol. 1975 Jul 15;211(3):185-92. doi: 10.1007/BF00455283.

DOI:10.1007/BF00455283
PMID:1243539
Abstract

48 rats were treated with the antihypertensive drug, guanethidine; its effects on the parotid glands (alpha-amylase content, protein concentration, and isamylase distribution patterns) were investigated. The treatment significantly increased the amylase activity in the gland extracts as well as the concentration of isoamylases and their specific enzyme activities. Moreover, we found a redistribution of activity between the 4 isoamylases of the parotid glands. The observed changes are the manifestations of a proteodyschylia concomitant with a peripheral neurogenic sialoadenosis. The described alterations are fully reversible within two weeks after discontinuation of the guanethidine application.

摘要

相似文献

1
[Sialoadenosis produced by drug-treatment of hypertonicity. I. Experimental studies on the effects of guanethidine (Ismelin) on the parotid glands of the rat (author's transl)].
Arch Otorhinolaryngol. 1975 Jul 15;211(3):185-92. doi: 10.1007/BF00455283.
2
Sialoadenosis produced by drug-treatment of hypertonicity. II. Experimental studies on the effects of guanethidine (Ismelin) on the submaxillary glands of the rat.由高渗性药物治疗引起的涎腺肿大。II. 胍乙啶(依斯美林)对大鼠下颌下腺影响的实验研究。
Arch Otorhinolaryngol. 1975 Dec 30;211(4):259-65. doi: 10.1007/BF00456346.
3
[The "stimulatory proteodyschylia" in the amitriptylin (Laroxyl) treated rat parotid gland. Experiments on the effect of antidepressive pharmacotherapy on the parotid glands of the rat (author's transl)].
Arch Otorhinolaryngol. 1977 Jun 30;217(1):61-7. doi: 10.1007/BF00453891.
4
Pharmacological inhibition of salivary glands: a possible therapy for sialosis and sialoadenitis. Effect of experimentally induced beta-receptor block on the rat parotid gland.
ORL J Otorhinolaryngol Relat Spec. 1976;38(4):218-29. doi: 10.1159/000275278.
5
[On a biochemical model of neurogenic sialosis: studies in rats (author's transl)].
Laryngol Rhinol Otol (Stuttg). 1975 Jul;54(7):542-50.
6
[Activity of parotid isoamylases in the ethionine-treated rat (author's transl)].[乙硫氨酸处理大鼠腮腺异淀粉酶的活性(作者译)]
Arch Otorhinolaryngol. 1978 Jan 30;218(3-4):247-51.
7
[Parotid gland sialadenitis. Physiology and physiopathology of parotid gland secretion].[腮腺涎腺炎。腮腺分泌的生理学与病理生理学]
Fortschr Med. 1978 Dec 1;96(45):2289-91.
8
[Parotid duct occlusion with prolamine--sequelae of long-term administration in the animal model].[腮腺导管用醇溶蛋白闭塞——动物模型中长期给药的后遗症]
HNO. 1984 Dec;32(12):507-10.
9
Effects of alpha- and beta-adrenergic receptor blockade on the isoamylases of rat-parotid gland.α-和β-肾上腺素能受体阻断对大鼠腮腺淀粉酶同工酶的影响。
Arch Otorhinolaryngol. 1978 Jun 27;220(3):187-92. doi: 10.1007/BF00457486.
10
The influence of guanoxane on the submaxillary glands of rats. Another model of neurogenic sialoses.
Acta Otolaryngol. 1976 May-Jun;81(5-6):507-12. doi: 10.3109/00016487609107508.

引用本文的文献

1
Possible involvement of parotid beta-adrenergic receptors in the etiology of sialadenosis.腮腺β-肾上腺素能受体可能参与涎腺肿大症的病因。
Arch Otorhinolaryngol. 1981;230(2):113-20. doi: 10.1007/BF00456140.
2
Sialoadenosis produced by drug-treatment of hypertonicity. II. Experimental studies on the effects of guanethidine (Ismelin) on the submaxillary glands of the rat.由高渗性药物治疗引起的涎腺肿大。II. 胍乙啶(依斯美林)对大鼠下颌下腺影响的实验研究。
Arch Otorhinolaryngol. 1975 Dec 30;211(4):259-65. doi: 10.1007/BF00456346.
3
[Clinical aspects of non-tumorous diseases of the salivary glands].

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
CLINICAL TRIAL OF 2-GUANIDINOMETHYL (1,4) BENZODIOXAN (COMPOUND 1003).2-胍基甲基(1,4)苯并二恶烷(化合物1003)的临床试验
Br Med J. 1964 Feb 15;1(5380):398-402. doi: 10.1136/bmj.1.5380.398.
3
[ON THE MECHANISM OF ACTION OF GUANETHIDINE].[关于胍乙啶的作用机制]
[唾液腺非肿瘤性疾病的临床方面]
Arch Otorhinolaryngol. 1976;213(1):1-59. doi: 10.1007/BF00462775.
4
Effects of alpha- and beta-adrenergic receptor blockade on the isoamylases of rat-parotid gland.α-和β-肾上腺素能受体阻断对大鼠腮腺淀粉酶同工酶的影响。
Arch Otorhinolaryngol. 1978 Jun 27;220(3):187-92. doi: 10.1007/BF00457486.
5
[The "stimulatory proteodyschylia" in the amitriptylin (Laroxyl) treated rat parotid gland. Experiments on the effect of antidepressive pharmacotherapy on the parotid glands of the rat (author's transl)].
Arch Otorhinolaryngol. 1977 Jun 30;217(1):61-7. doi: 10.1007/BF00453891.
Arztl Forsch. 1963 Sep 10;17:498-501.
4
Determination of amylase activity in biological fluids.生物体液中淀粉酶活性的测定。
Clin Chim Acta. 1956 May-Jun;1(3):256-68. doi: 10.1016/0009-8981(56)90072-9.
5
Function of rat parotid gland after sympathectomy and total postganglionectomy.大鼠交感神经切除和节后神经全切除后腮腺的功能
Am J Physiol. 1966 Oct;211(4):943-9. doi: 10.1152/ajplegacy.1966.211.4.943.
6
Prolonged hypotension and ultrastructural changes in sympathetic neurones following guanacline treatment.
Eur J Pharmacol. 1971 Jan;13(2):175-87. doi: 10.1016/0014-2999(71)90148-8.
7
[Hazards of the modern antihypertensive therapy].
Z Allgemeinmed. 1970 Sep 20;46(26):1287-90.
8
A new method of destroying adrenergic nerves in adult animals using guanethidine.一种使用胍乙啶破坏成年动物肾上腺素能神经的新方法。
Br J Pharmacol. 1971 Oct;43(2):295-301.
9
[Irreversible parotid gland pain following administration of guanaclin].
Dtsch Med Wochenschr. 1971 Oct 15;96(42):1649-50.
10
Effect of postganglionic sympathectomy on the ultrastructure of the rat parotid gland.节后交感神经切除术对大鼠腮腺超微结构的影响。
Z Zellforsch Mikrosk Anat. 1972;130(4):471-80. doi: 10.1007/BF00307001.